Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
We report a case with menorrhagia due to uterine fibroids who was admitted following an episode of unstable angina. Her coronary angiogram showed a tight proximal left anterior descending artery lesion for which stenting was deemed necessary. She was successfully anticoagulated in spite of her menorrhagia under cover of a gonadotrophin hormone releasing agonist; goserilin.
Khurana
C
C
Cardiothoracic Division, South Cleveland Hospital, Middlesbrough, UK.
Taylor
P
P
de Belder
M A
MA
D000789:Angina, Unstable / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D017023:Coronary Angiography; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D007889:Leiomyoma / Q000150:complications / Q000188:drug therapy; D008595:Menorrhagia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D015607:Stents; D014594:Uterine Neoplasms / Q000150:complications / Q000188:drug therapy
D018931:Antineoplastic Agents, Hormonal; D006454:Hemoglobins; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone